Shopping Cart 0
Cart Subtotal
USD 0

GenKyoTex SA (GKTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

GenKyoTex SA (GenKyoTex), formerly Genticel SA, is a biopharmaceutical company that develops NOX therapies. The company develops targeted NOX inhibitors and molecule therapeutics that inhibit the NOX family of enzymes. GenKyoTex's lead product candidate, GKT831, a selective NOX1/4 inhibitor, is in phase II clinical trial in primary biliary cholangitis, type 1 diabetes and kidney disease, and idiopathic pulmonary fibrosis. Its second product candidate, GKT771, currently under preclinical testing, is a NOX1 inhibitor that targets multiple pathways in angiogenesis, pain processing, and inflammation. The company's products are used in the treatment of diabetic nephropathy. The company has operations in Switzerland and France. GenKyoTex is headquartered in Saint-Julien- en-Genevois, France.

GenKyoTex SA (GKTX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

GenKyoTex SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

GenKyoTex SA, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

GenKyoTex Raises USD21 Million in Series D Financing 11

GenKyoTex Raises USD 26 Million In Extended Series C Financing 13

Merger 15

Genticel Merges with GenKyoTex 15

Licensing Agreements 17

Serum Institute Expands Licensing Agreement with Genkyotex 17

Equity Offering 18

GenKyoTex Plans to Raise Funds through IPO 18

Debt Offering 19

Genkyotex to Raise USD5.7 Million in Private Placement of 15% First Tranche Notes Due 2019 19

GenKyoTex SA-Key Competitors 21

GenKyoTex SA-Key Employees 22

GenKyoTex SA-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Sep 26, 2018: Genkyotex reports first-half 2018 financial results 24

Feb 28, 2018: Genkyotex Reports 2017 Financial Results 26

Oct 26, 2017: Genkyotex Provides Business Update for Q3 2017 28

Sep 21, 2017: Genkyotex Announces 2017 First-Half Financial Results 29

Apr 27, 2017: Genkyotex Provides Business Update for Q1 2017 30

Product News 31

10/26/2017: Genkyotex Provides Business Update For Q3 2017 31

Clinical Trials 32

May 07, 2018: Genkyotex Announces Positive Outcome from Independent SMB's First Pre-Planned Review of GKT831's Phase 2 Trial in Primary Biliary Cholangitis 32

Aug 03, 2017: Genkyotex's GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts 33

Jun 27, 2017: Genkyotex Initiates Patient Enrollment into Phase 2 Trial of GKT831 in Primary Biliary Cholangitis 34

May 02, 2017: Genkyotex Announces FDA Approval of IND for Phase 2 Trial of GKT831 in Patients with Primary Biliary Cholangitis 35

Other Significant Developments 36

Apr 25, 2018: Genkyotex Reports March 31, 2018 Cash Position and Provides Business Update 36

Jan 31, 2018: Genkyotex Reports December 31, 2017 Cash Position and Provides Business Update 37

Jul 27, 2017: Genkyotex Provides Business Update for Q2 2017 38

Jun 05, 2017: Edison Issues Outlook on Genkyotex 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

GenKyoTex SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

GenKyoTex SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

GenKyoTex SA, Deals By Therapy Area, 2012 to YTD 2018 9

GenKyoTex SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

GenKyoTex Raises USD21 Million in Series D Financing 11

GenKyoTex Raises USD 26 Million In Extended Series C Financing 13

Genticel Merges with GenKyoTex 15

Serum Institute Expands Licensing Agreement with Genkyotex 17

GenKyoTex Plans to Raise Funds through IPO 18

Genkyotex to Raise USD5.7 Million in Private Placement of 15% First Tranche Notes Due 2019 19

GenKyoTex SA, Key Competitors 21

GenKyoTex SA, Key Employees 22

GenKyoTex SA, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

GenKyoTex SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.